{
  "id": 7785833,
  "title": "Rubedo Life Sciences Announces Clinical Study to Treat Hair Loss with GPX4 Modulator RLS-1496, First Human Ex Vivo Evidence Demonstrates Robust Hair Follicle Growth",
  "url": "https://urgent.news/2026/09/16/rubedo-life-sciences-announces-clinical-study-to-treat-hair-loss-with",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-16T12:23:14.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/rubedo-life-sciences-announces-clinical-study-to-treat-hair-loss-with-gpx4-modulator-rls-1496-first-human-ex-vivo-evidence-demonstrates-robust-hair-follicle-growth"
  },
  "original_language": "en",
  "account": null,
  "summary": "AGA clinical trial to begin in Fall 2026 led by David Pariser, MD, FACP, FAAD, former President of the American Academy of Dermatology and Principal Investigator in more than 450 dermatology clinical trials Rubedo’s RLS-1496, the first and only GPX4 modulator currently in clinical trials, demonstrates superior hair follicle restoration in human ex vivo androgenetic […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}